Literature DB >> 21375786

Bell's palsy.

Julian Holland1, Jonathan Bernstein.   

Abstract

INTRODUCTION: Bell's palsy is characterised by an acute, unilateral, partial, or complete paralysis of the face (i.e., lower motor neurone pattern). The weakness may be partial (paresis) or complete (paralysis), and may be associated with mild pain, numbness, increased sensitivity to sound, and altered taste. Bell's palsy remains idiopathic, but a proportion of cases may be caused by reactivation of herpes viruses from the geniculate ganglion of the facial nerve. Bell's palsy is most common in people aged 15 to 40 years, with a 1 in 60 lifetime risk. Most make a spontaneous recovery within 1 month, but up to 30% show delayed or incomplete recovery. METHODS AND OUTCOMES: We conducted a systematic review to answer the following clinical question: What are the effects of treatments in adults and children? We searched: Medline, Embase, The Cochrane Library, and other important databases up to June 2010 (Clinical Evidence reviews are updated periodically. Please check our website for the most up-to-date version of this review). We included harms alerts from relevant organisations such as the US Food and Drug Administration (FDA) and the UK Medicines and Healthcare products Regulatory Agency (MHRA).
RESULTS: We found 14 systematic reviews, RCTs, or observational studies that met our inclusion criteria. We performed a GRADE evaluation of the quality of evidence for interventions.
CONCLUSIONS: In this systematic review we present information relating to the effectiveness and safety of the following interventions: antiviral treatment, corticosteroids (alone or plus antiviral treatment), hyperbaric oxygen therapy, facial nerve decompression surgery, and facial retraining.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21375786      PMCID: PMC3275144     

Source DB:  PubMed          Journal:  BMJ Clin Evid        ISSN: 1462-3846


  26 in total

1.  Reactivation of herpes simplex virus type 1 and varicella-zoster virus and therapeutic effects of combination therapy with prednisolone and valacyclovir in patients with Bell's palsy.

Authors:  Kazuhiro Kawaguchi; Hiroo Inamura; Yasuhiro Abe; Hidehiro Koshu; Emi Takashita; Yasushi Muraki; Yoko Matsuzaki; Hidekazu Nishimura; Hitoshi Ishikawa; Akira Fukao; Seiji Hongo; Masaru Aoyagi
Journal:  Laryngoscope       Date:  2007-01       Impact factor: 3.325

Review 2.  Effects of exercises on Bell's palsy: systematic review of randomized controlled trials.

Authors:  Jefferson Rosa Cardoso; Elsie Cobra Teixeira; Michelle Damasceno Moreira; Francis Meire Fávero; Sissy Veloso Fontes; Acary Souza Bulle de Oliveira
Journal:  Otol Neurotol       Date:  2008-06       Impact factor: 2.311

3.  Surgical management of Bell's palsy.

Authors:  B J Gantz; J T Rubinstein; P Gidley; G G Woodworth
Journal:  Laryngoscope       Date:  1999-08       Impact factor: 3.325

4.  Hyperbaric oxygen as a therapy of Bell's palsy.

Authors:  G Racic; P J Denoble; N Sprem; L Bojic; B Bota
Journal:  Undersea Hyperb Med       Date:  1997       Impact factor: 0.698

5.  Lyme disease and seventh nerve paralysis in children.

Authors:  S P Cook; K K Macartney; C D Rose; P G Hunt; S C Eppes; J S Reilly
Journal:  Am J Otolaryngol       Date:  1997 Sep-Oct       Impact factor: 1.808

6.  Stability of benefits of mime therapy in sequelae of facial nerve paresis during a 1-year period.

Authors:  Carien H G Beurskens; Peter G Heymans; Rob A B Oostendorp
Journal:  Otol Neurotol       Date:  2006-10       Impact factor: 2.311

7.  Bell palsy and herpes simplex virus: identification of viral DNA in endoneurial fluid and muscle.

Authors:  S Murakami; M Mizobuchi; Y Nakashiro; T Doi; N Hato; N Yanagihara
Journal:  Ann Intern Med       Date:  1996-01-01       Impact factor: 25.391

8.  Idiopathic facial nerve palsy in children and the effect of treatment with steroids.

Authors:  C A Prescott
Journal:  Int J Pediatr Otorhinolaryngol       Date:  1987-10       Impact factor: 1.675

9.  Early treatment with prednisolone or acyclovir in Bell's palsy.

Authors:  Frank M Sullivan; Iain R C Swan; Peter T Donnan; Jillian M Morrison; Blair H Smith; Brian McKinstry; Richard J Davenport; Luke D Vale; Janet E Clarkson; Victoria Hammersley; Sima Hayavi; Anne McAteer; Ken Stewart; Fergus Daly
Journal:  N Engl J Med       Date:  2007-10-18       Impact factor: 91.245

10.  Valacyclovir and prednisolone treatment for Bell's palsy: a multicenter, randomized, placebo-controlled study.

Authors:  Naohito Hato; Hiroyuki Yamada; Hisashi Kohno; Shuichi Matsumoto; Nobumitsu Honda; Kiyofumi Gyo; Satoshi Fukuda; Yasushi Furuta; Fumio Ohtani; Hiroshi Aizawa; Masaru Aoyagi; Hiroo Inamura; Tsutomu Nakashima; Seiichi Nakata; Shingo Murakami; Jun Kiguchi; Koji Yamano; Taizo Takeda; Masashi Hamada; Kazuhiro Yamakawa
Journal:  Otol Neurotol       Date:  2007-04       Impact factor: 2.311

View more
  5 in total

1.  The Diagnosis and Treatment of Idiopathic Facial Paresis (Bell's Palsy).

Authors:  Josef Georg Heckmann; Peter Paul Urban; Susanne Pitz; Orlando Guntinas-Lichius; Ildikό Gágyor
Journal:  Dtsch Arztebl Int       Date:  2019-10-11       Impact factor: 5.594

2.  Economic Impact of Diagnostic Imaging in the Workup of Uncomplicated Bell's Palsy.

Authors:  Elycia Kazemian; Hollie Marie Schaffer; Amy Wozniak; John P Leonetti
Journal:  J Neurol Surg B Skull Base       Date:  2021-01-21

3.  Bell's palsy as a possible complication of mRNA-1273 (Moderna) vaccine against COVID-19.

Authors:  Sujan Poudel; Prakash Nepali; Santosh Baniya; Sangam Shah; Sunil Bogati; Gaurav Nepal; Rajeev Ojha; Omoyeme Edaki; Gavrilo Lazovic; Sam Kara
Journal:  Ann Med Surg (Lond)       Date:  2022-05-31

4.  Electroacupuncture Is Effective for Peripheral Facial Paralysis: A Meta-Analysis.

Authors:  Wei-Hua Wang; Ruo-Wen Jiang; Na-Chuan Liu
Journal:  Evid Based Complement Alternat Med       Date:  2020-03-31       Impact factor: 2.629

5.  Electroacupuncture combined with Qianzhengsan decoction for the treatment of peripheral facial paralysis: A retrospective study.

Authors:  Wei-Qiang Chen; Qiang Li
Journal:  Medicine (Baltimore)       Date:  2022-09-16       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.